pharmaceutical investing Zealand Pharma Doses First Patient in Phase 3 Trial with Dasiglucagon for Treatment of Congenital Hyperinsulinism
pharmaceutical investing Zealand Pharma achieves primary and key secondary endpoints in pivotal Phase 3 trial with dasiglucagon for severe hypoglycemia
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
Homerun Resources Inc. Receives Joint Support Plan from BNDES and FINEP Indicating Financial Instruments Available to Support Homerun's Business Plan
Allied Critical Metals Launches Allied USA to Expand Tungsten Import and Distribution Operations, Lists on OTCQB, and Receives DTC Eligibility
Anteros Metals Initiates Channel Sampling at Havens Steady Following Grant Confirmation and Exploration Permit Approval
